Pfizer Inc. acquired the worldwide pharmaceutical, animal health and human products business from Pharmacia Corporation for approximately US$57 billion. The deal closed on April 17, 2003. In Canada, the merger involved obtaining the approval of the Competition Bureau and arranging for the divestiture of three pipeline products of the companies.
Pfizer Canada Inc.’s in-house legal team was led by John Rudolph, and included Tania Tretiak and Stephanie Pearl in Montreal and Karyn Pellatt in Toronto. Pfizer Canada was also represented by Cassels Brock & Blackwell LLP, with a team led by Phil Spencer, Q.C., and including Frank Monteleone, Carol Anne O’Brien and Megan Evans (competition), Stuart English, Jason Klein, Maria Rossi, Max Leveson and Cheryl Silver (business), Rick Angelson (real estate), John McGowan (environmental) and Emily Winter (litigation); and by Geoffrey Lawson of Barsalou Lawson (tax) in Montreal.
Pharmacia Canada’s in-house legal team was led by Amita Kent. Pharmacia was also represented by Borden Ladner Gervais LLP, with a team that included Adam Fanaki and Ross DeBoni (competition), Paul Mingay (securities), Jim Elder (corporate), Randall Echlin and Matthew Certosimo (employment) and Sean Weir, Andrew Harrison, Freya Kristjanson, Markus Kremer and Sonia Mak (pensions).